Uterine fibroids, reproductive health of women after surgical treatment

• Alina V. Solovieva
• Nikolay G. Fedotov

Abstract

Background. Uterine fibroids are the most common benign tumor in women of reproductive age. It is often the cause of abnormal uterine bleeding (UBH), pelvic pain and reproductive disorders: infertility and miscarriage. Widespread organ-preserving surgeries for uterine fibroids often do not lead to pain relief and AMC, and arealso associated with unfavorable perinatal outcomes: a high incidence of preterm birth and miscarriage.

The aim of the study was to analyze modern scientific publications on the prevalence of fibroids, the causes of abnormal uterine bleeding against the background of fibroids, and the state of women's reproductive health after myomectomy.

Material and methods. Articles over the past 15 years from PubMed, Embase, Medline, Cochrane databases, including case series and registries related to AMC, reproductive disorders associated with uterine fibroids, and long-term outcomes after myomectomy.

Conclusion. In women, after myomectomy, AMK, pain and reproductive disorders often persist. This requires new research in this area, with the aim of developing comprehensive methods for improving the health of women with fibroids.

Keywords:uterine myoma, abnormal uterine bleeding, reproductive disorders, myomectomy

References

1. Li Y., Qian W., Griffin B.B., Gao T., Chakravarti D., Bulum S., et al. HMGA2-mediated tumorigenesis through angiogenesis in leiomyoma. Fertil Steril. 2020; 114 (5): 1085-96.

2. Vilos G.A., Allaire C., Laberge Ph.-Y. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2015; 37 (2): 157-78. DOI: https://doi.org/10.1016/S1701-2163(15)30338-8

3. Zimmermann A., Bernuit D., Gerlinger C., Schaefers M., Geppert K. Prevalence, symptoms and management of uterine broids: an international Internet-based survey of 21,746 women. BMC Womens Health. 2012; 12: 6.

4. Moshesh M., Olshan A.F., et al. Examining the relationship between fibroids and dyspareunia among premenopausal women in the US. J Sex Med. 2014; 11 (3): 800-8.

5. Canadian Institute for Health Information, Statistics Canada. Health indicators. Ottawa: CIHI, 2010. URL: https://secure.cihi.ca/free_products/Healthindica-tors2010 (date of access November 10, 2014)

6. Blood-saving technologies in gynecological practice. Clinical protocol. Moscow, 2015. (in Russian)

7. Clark-Pearson D.L., Geller E.L. Complications of hysterectomy. Obstet. Gynecol. 2013; 121: 654-73.

8. Laughlin-Tommaso Sh.K., Jacoby V.L., Myers E.R. Disparities in fibroid incidence, prognosis, and management. Obstet Gynecol Clin North Am. 2017; 44 (1): 81-94.

9. Munro M.G., Critchley H.O.D., Fraser I.S. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynecol Obstet. 2018; 143 (3): 393-408.

10. Wegienka G., Baird D.D., Hertz-Picciotto I., et al. Self-reported heavy bleeding associated with uterine leiomyomata. Obstet Gynecol. 2003; 101 (3): 431-7.

11. Aguilar H.N., Mitchell B.F. Physiological pathways and molecular mechanisms regulating uterine contractility. Hum Reprod Update. 2010; 16 (6): 725-44.

12. Hickey M., Fraser I. Human uterine vascular structures in normal and diseased states. Microsc Res Tech. 2003; 60 (4): 377-89.

13. Parker W.H. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril. 2007; 87 (4): 725-36.

14. Tal R., Segar J.H. The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy. Hum Reprod Update. 2014; 20 (2): 194-216.

15. Hapangama D.K., Bulmer J.N. Pathophysiology of heavy menstrual bleeding. Womens Health. 2016; 12 (1): 3-13.

16. Majak G.B., Lieng M., Qvigstad E. Clinical outcome after laparoscopic and open abdominal myomectomy. Gynecol Surg. 2012; 9: 231-4.

17. Radzinskiy V.E., Totchiev G.F. Uterine myoma: course on organ preservation. Newsletter. Moscow: Redaktsiya zhurnala StatusPraesens, 2014: 24 p. (in Russian)

18. Zepiridis L.I., Grimbizis G.F., Tarlatzis B.C. Infertility and uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016; 34: 66-73.

19. Sundermann A.C., Velez Edwards D.R., Bray M.J., Jones S.H., Latham S.M., Hartmann K.E. Leiomyomas in pregnancy and spontaneous abortion: a systematic review and meta-analysis. Obstet Gynecol. 2017; 130 (5): 1065-72.

20. Uterine myoma: diagnosis, treatment and rehabilitation: clinical guidelines (treatment protocol). Moscow: Minzdrav RF, 2015. (in Russian)

21. Donnez J., Dolmans M.-M. Uterine fibroid management: from the present to the future. Hum Reprod Update. 2016; 22 (6): 665-86.

22. Sleiman Z., El Baba R., Garzon S., Khazaka A. The significant risk factors of intra-operative hemorrhage during laparoscopic myomectomy: a systematic review. Gynecol Minim Invasive Ther. 2019; 9 (1): 6-12.

23. Fujimoto A., Morimoto C., Hosokawa Y., Hasegawa A. Suturing method as a factor for uterine vascularity after laparoscopic myomectomy. Eur J Obstet Gynecol Reprod Biol. 2017; 211: 146-9. DOI: http://dx.doi.org/10.1016Zj.ejogrb.2017.02.027

24. Shin D.G., Yoo H.J., et al. Recurrence factors and reproductive outcomes of laparoscopic myomectomy and minilaparotomic myomectomy for uterine leiomyomas. Obstet Gynecol Sci. 2017; 60 (2): 193-9.

25. Yoo E.H., Lee P.I., Huh C.Y., Kim D.H., Lee B.S., Lee J.K., et al. Predictors of leiomyoma recurrence after laparoscopic myomectomy. J Minim Invasive Gynecol. 2007; 14: 690-7.

26. Al-Mahrizi S., Tulandi T. Treatment of uterine broids for abnormal uterine bleeding: myomectomy and uterine artery embolization. Best Pract Res Clin Obstet Gynaecol. 2007; 21: 995-1005.

27. Taylor H.S. Fibroids: when should they be removed to improve in vitro fertilization success? Fertil Steril. 2018; 109 (5): 784-5.

28. Shue S., Radeva M., Falcone T. Fertility outcomes after myomectomy: relationship with number of fibroids removed. Fertil Steril. 2017; 108 (3): E208-E209.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)